Neoadjuvant intralesional methotrexate for juvenile xanthogranuloma in an adult

Dermatol Ther. 2022 Jan;35(1):e15200. doi: 10.1111/dth.15200. Epub 2021 Nov 16.

Authors

Alejandra Tomás-Velázquez¹, Miguel Reyes-Múgica², Alberto González-Menchen³, Ángela Estenaga¹, Javier Antoñanzas¹, Ana Morelló-Vicente¹, Rafael Salido-Vallejo¹

Affiliations

¹ Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Pamplona, Spain.
² Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
³ Department of Pathology, Reina Sofía University Hospital, Córdoba, Spain.

PMID: 34761843
DOI: 10.1111/dth.15200

No abstract available

Publication types

Letter

MeSH terms

Adult
Humans
Methotrexate*
Neoadjuvant Therapy
Xanthogranuloma, Juvenile* / diagnosis
Xanthogranuloma, Juvenile* / drug therapy

Substances

Methotrexate